Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06071299 · ClinicalTrials.gov registry record · NA
Impact of Family-Centered Care for Intimate Partner Violence (IPV)
A NA study of Intimate Partner Violence, sponsored by Yale University.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 2
- Study locations
NCT06071299: Active NA study of Intimate Partner Violence, sponsored by Yale University.
NCT06071299 is a NA study of Intimate Partner Violence that is active but no longer recruiting, run by Yale University. The registered enrollment target is 200 participants, below the 343-participant average among 14 other Intimate Partner Violence trials with a reported enrollment target (42% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06071299, a NA study of Intimate Partner Violence, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study will be to determine how participation in Family-Centered Care (FCC) compared to Child-centered care (CCC) will affect caregiver engagement in IPV-based community services, caregiver perceptions of empowerment and survivor-defined practice, and clinical outcomes for children exposed to IPV.
Primary Outcome
Percentage of caregivers who have at least one follow-up visit with an IPV advocate by 3 months after the initial visit by self-report.
Conditions Studied
Interventions
- BEHAVIORAL FCC
- BEHAVIORAL CCC
Study Locations (2)
Connecticut
- SCAN Clinic - Hartford
- The South Central Child Advocacy Center - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-01-10 |
| Est. Completion | 2026-12-15 |
| Phase | NA |
What the registry record for NCT06071299 still lists
NCT06071299 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 343-participant average among 14 other Intimate Partner Violence trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Intimate Partner Violence appearing as the primary indexed condition, and to 2 interventions - of which FCC is the first listed.
NCT06071299 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06071299 about?
NCT06071299 is a clinical study titled "Impact of Family-Centered Care for Intimate Partner Violence (IPV)". The purpose of the study will be to determine how participation in Family-Centered Care (FCC) compared to Child-centered care (CCC) will affect caregiver engagement in IPV-based community services, caregiver perceptions of empowerment and survivor-defined practice, and clinical outcomes for children...
What is the current status of trial NCT06071299?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-01-10. Estimated completion is 2026-12-15.
What conditions does trial NCT06071299 study?
This clinical trial studies the following conditions: Intimate Partner Violence.
What interventions are being tested in trial NCT06071299?
The interventions under investigation include: FCC (BEHAVIORAL), CCC (BEHAVIORAL).
Who is sponsoring clinical trial NCT06071299?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06071299 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intimate Partner Violence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06071299's enrollment target sits among peer trials
200 8th of 14 higher than 7 of 14 other Intimate Partner Violence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intimate Partner Violence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Virtual Village for Young Parents
RECRUITING · NA
-
Multifaceted Intervention to Restore Resilience and Overcome Risk
RECRUITING · NA
-
Empowering Young Parents: Building Healthy Relationships Study
RECRUITING · NA
-
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
RECRUITING · NA
-
Evaluating Interventions for Intimate Partner Violence Use in Washington State
RECRUITING · NA
-
Perceptions of Trauma and Violence Informed Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI